Chiome Bioscience Inc.
4583.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥16 | ¥7 | ¥8 | ¥8 |
| - Cash | ¥2 | ¥1 | ¥2 | ¥2 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥14 | ¥6 | ¥6 | ¥6 |
| Revenue | ¥1 | ¥1 | ¥1 | ¥1 |
| % Growth | 14.4% | 8.2% | -11.5% | – |
| Gross Profit | ¥0 | ¥0 | ¥0 | ¥0 |
| % Margin | 55.4% | 58.4% | 55.3% | 59.3% |
| EBITDA | -¥1 | -¥1 | -¥1 | -¥1 |
| % Margin | -129.8% | -177.6% | -195.8% | -205.1% |
| Net Income | -¥1 | -¥1 | -¥1 | -¥1 |
| % Margin | -130.7% | -178.8% | -197% | -207.6% |
| EPS Diluted | -17.54 | -24.62 | -28.26 | -36.74 |
| % Growth | 28.8% | 12.9% | 23.1% | – |
| Operating Cash Flow | -¥1 | -¥1 | -¥1 | -¥1 |
| Capital Expenditures | ¥0 | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | -¥1 | -¥1 | -¥1 | -¥1 |